Efficacy of two hemodialyses in patients with chronic renal failure complicated by massive intracerebral hemorrhage

Ann Clin Transl Neurol. 2023 Jul;10(7):1186-1199. doi: 10.1002/acn3.51800. Epub 2023 Jun 23.

Abstract

Objective: To compare the efficacy of intermittent hemodialysis (IHD) and continuous veno-venous hemofiltration (CVVH) in patients with chronic renal failure complicated by massive intracerebral hemorrhage.

Methods: Sixty-two patients were randomly and equally divided into IHD and CVVH groups. The clinical variables were compared, including National Institutes of Health Stroke Scale (NIHSS) score as the primary indicator, cerebral edema volume, hospital-acquired pneumonia (HAP) incidence, acute heart failure (AHF) incidence, rehemorrhage incidence, hospital stay length, and modified Rankin Scale (mRS) score.

Results: The CVVH group had lower NIHSS scores and edema volumes than the IHD group on postoperative days 7 and 14. Moreover, in the CVVH group, (i) the NIHSS scores on postoperative days 3 and 7 were higher than those on postoperative day 1; (ii) there was no significant difference in NIHSS scores between days 14 and 1; and (iii) no significant difference in cerebral edema volume was found between postoperative days 1 and 3, 7, and 14. In the IHD group, the NIHSS scores and cerebral edema volume on postoperative days 7 and 14 were significantly higher than those on postoperative day 1. The CVVH group had a lower incidence of HAP, AHF, and adverse events and shorter hospital stay length than the IHD group. The proportions of patients with mRS scores of 1 and 2 in the CVVH group were higher than those in the IHD group on day 30 after discharge.

Interpretation: CVVH is more effective than IHD in the treatment of patients with chronic renal failure complicated by massive intracerebral hemorrhage.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / epidemiology
  • Acute Kidney Injury* / etiology
  • Acute Kidney Injury* / therapy
  • Brain Edema* / epidemiology
  • Brain Edema* / etiology
  • Cerebral Hemorrhage / therapy
  • Hemofiltration* / adverse effects
  • Humans
  • Kidney Failure, Chronic* / complications
  • Kidney Failure, Chronic* / therapy
  • Renal Dialysis / adverse effects
  • United States

Grants and funding

This work was funded by Excellent Teaching Team of “Qinglan Project”; Xuzhou National Clinical Key Specialty Cultivation Project grant 2018ZK004; Jiangsu Provincial Commission of Health and Family Planning grant LGY2019085; The Excellent Young and Middle‐Aged Talents Project of the affiliated hospital of Xuzhou Medical University grant 2019128009; National Keypoint Research and Invention Program grant 2020YFC1512704; Xuzhou Medical Leading Talent Training Project grant XWRCHT20210026.